Mark B Skaletsky - Net Worth and Insider Trading
Mark B Skaletsky Net Worth
The estimated net worth of Mark B Skaletsky is at least $828 dollars as of 2024-11-13. Mark B Skaletsky is the Director of Catalyst Biosciences Inc and owns about 108 shares of Catalyst Biosciences Inc (CBIO) stock worth over $828. Details can be seen in Mark B Skaletsky's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark B Skaletsky has not made any transactions after 2010-11-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark B Skaletsky
Mark B Skaletsky Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark B Skaletsky owns 5 companies in total, including Alkermes PLC (ALKS) , Catalyst Biosciences Inc (CBIO) , and Immunogen Inc (IMGN) among others .
Click here to see the complete history of Mark B Skaletsky’s form 4 insider trades.
Insider Ownership Summary of Mark B Skaletsky
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALKS | Alkermes PLC | 2011-09-16 | director |
| CBIO | Catalyst Biosciences Inc | 2010-11-17 | director |
| IMGN | Immunogen Inc | 2003-06-12 | director |
 | | 2008-12-19 | director |
| | 2003-07-01 | director |
Mark B Skaletsky Latest Holdings Summary
Mark B Skaletsky currently owns a total of 1 stock. Mark B Skaletsky owns 108 shares of Catalyst Biosciences Inc (CBIO) as of November 17, 2010, with a value of $828.
Latest Holdings of Mark B Skaletsky
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CBIO | Catalyst Biosciences Inc | 2010-11-17 | 108 | 7.67 | 828 |
Holding Weightings of Mark B Skaletsky
Mark B Skaletsky Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark B Skaletsky has made a total of 0 transactions in Catalyst Biosciences Inc (CBIO) over the past 5 years. The most-recent trade in Catalyst Biosciences Inc is the sale of 310 shares on November 17, 2010, which brought Mark B Skaletsky around $714,350.
Insider Trading History of Mark B Skaletsky
- 1
Mark B Skaletsky Trading Performance
Mark B Skaletsky Ownership Network
Ownership Network List of Mark B Skaletsky
Ownership Network Relation of Mark B Skaletsky
Mark B Skaletsky Owned Company Details
What does Alkermes PLC do?
Who are the key executives at Alkermes PLC?
Mark B Skaletsky is the director of Alkermes PLC. Other key executives at Alkermes PLC include SVP & Med Dev/Med Affairs & CMO Craig C. Hopkinson , SVP & Chief Commercial Officer Christian Todd Nichols , and SVP & Corp Dev. & Alkermes & Inc. Michael J Landine .
Alkermes PLC (ALKS) Insider Trades Summary
Over the past 18 months, Mark B Skaletsky made no insider transaction in Alkermes PLC (ALKS). Other recent insider transactions involving Alkermes PLC (ALKS) include a net sale of 8,128 shares made by Cato T Laurencin , a net sale of 69,467 shares made by Craig C. Hopkinson , and a net sale of 37,551 shares made by Christian Todd Nichols .
In summary, during the past 3 months, insiders sold 69,467 shares of Alkermes PLC (ALKS) in total and bought 0 shares, with a net sale of 69,467 shares. During the past 18 months, 117,705 shares of Alkermes PLC (ALKS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 117,705 shares.
Alkermes PLC (ALKS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alkermes PLC Insider Transactions
Mark B Skaletsky Mailing Address
Above is the net worth, insider trading, and ownership report for Mark B Skaletsky. You might contact Mark B Skaletsky via mailing address: 1896 Rutherford Road, Carlsbad Ca 92008.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
